Quoc Le-Nguyen

Chief Tech/Sci/R&D Officer at 89BIO, INC.

Net worth: 2 M $ as of 29/04/2024

56 year

Health Technology

Consumer Services

Quoc Le-Nguyen active positions

Companies	Position	Start	End
89BIO, INC.	Chief Tech/Sci/R&D Officer	28/02/2019	-

Companies	Position	Start	End
CHINOOK THERAPEUTICS, INC.	Corporate Officer/Principal	31/08/2015	30/06/2018
BAYER AG	Corporate Officer/Principal	31/08/2007	31/08/2013

University of California

Undergraduate Degree

International

United States	4
Germany	2

Operational

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
89BIO, INC.	Health Technology
BAYER AG	Health Technology

Private companies	1
Aduro BioTech, Inc. Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.	Health Technology

Private companies

Health Technology